{"id":"W2060260809","doi":"10.1186/s40425-015-0055-3","title":"Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results","year":2015,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Immunotherapy; Internal medicine; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Surgery; Urology; Gastroenterology; Overall survival; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008618499,0.0007077394,0.0009243816,0.0001978206,0.0002141753,0.0004603866,0.0002972696,0.0003715264,0.001109857],"category_scores_gemma":[0.0003012223,0.0001729603,0.0006741517,0.0001602708,0.0003696362,0.0002686872,0.0001724766,0.001107144,0.0002285928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005340033,"about_ca_system_score_gemma":0.0007319496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005284023,"about_ca_topic_score_gemma":0.001320145,"domain_scores_codex":[0.9998016,0.00008328175,0.00001284796,0.0000361208,0.00002972928,0.00003644943],"domain_scores_gemma":[0.9997461,0.00003674179,0.00005368014,0.00001654914,0.00001776774,0.0001291186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5532104,0.06604856,0.04498233,0.0007940667,0.002140777,0.0004981002,0.0004640956,0.005314764,0.1472822,0.0001660989,0.002680096,0.1764184],"study_design_scores_gemma":[0.2139255,0.6678697,0.08811148,0.00003733647,0.001101507,0.0008142737,0.00007159962,0.003468501,0.02102266,0.0001340164,0.00340023,0.00004318481],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987072,0.0005700512,0.0001503042,0.00005890276,0.00001246393,0.0001262879,0.0001142173,0.00001805196,0.0002425605],"genre_scores_gemma":[0.9979463,0.0003872165,0.0004471341,0.00008409673,0.0000296328,0.0001669557,0.0005362182,0.000007632441,0.0003948727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001109857,"threshold_uncertainty_score":0.004557967,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02350134221702204,"score_gpt":0.3124838008042494,"score_spread":0.2889824585872273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}